Kim Bouillon
Overview
Explore the profile of Kim Bouillon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Botton J, Bertrand M, Jabagi M, Duranteau L, Bouillon K, Drouin J, et al.
Vaccine
. 2024 Sep;
42(24):126252.
PMID: 39226788
Background: COVID-19 vaccination has been inconsistently associated with an increased risk of heavy menstrual bleeding in previous studies. This study aimed to assess the risk of heavy menstrual bleeding requiring...
2.
Turpin A, Semenzato L, Le Vu S, Jabagi M, Bouillon K, Drouin J, et al.
J Infect Public Health
. 2024 Jun;
17(7):102450.
PMID: 38823086
Background: In spite of major effectiveness, a residual risk after COVID-19 primary vaccination was identified, in particular, for vulnerable individuals of advanced age or with comorbidities. Less is known about...
3.
Bouillon K, Baricault B, Botton J, Jabagi M, Bertrand M, Semenzato L, et al.
BMJ Med
. 2023 Mar;
1(1):e000104.
PMID: 36936561
Objective: To estimate the effectiveness of the three covid-19 vaccines by Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273), and Oxford-AstraZeneca (ChAdOx1-S) in people after receiving two doses. Design: Cohort study. Setting: Nationwide, population...
4.
Roland N, Baricault B, Weill A, Bouillon K, Dray-Spira R, Duranteau L, et al.
JAMA
. 2022 Dec;
329(3):257-259.
PMID: 36548007
No abstract available.
5.
Bouillon K, Baricault B, Semenzato L, Botton J, Bertrand M, Drouin J, et al.
J Am Heart Assoc
. 2022 Jun;
11(12):e023357.
PMID: 35699173
Background There is little evidence on the relationship between statin use and the risk of hospitalization attributable to COVID-19. Methods and Results The French National Healthcare Data System database was...
6.
Gil-Salcedo A, Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Schnitzler A, et al.
PLoS Med
. 2020 Jul;
17(7):e1003147.
PMID: 32628661
Background: Frailty is associated with increased risk of various health conditions, disability, and death. Health behaviors are thought to be a potential target for frailty prevention, but the evidence from...
7.
Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Ben Rayana T, Schnitzler A, et al.
Lancet Public Health
. 2019 Dec;
5(1):e42-e50.
PMID: 31837974
Background: Social inequalities in mortality persist in high-income countries with universal health care, and the mechanisms by which these inequalities are generated remain unclear. We aimed to examine whether social...
8.
Bouillon K, Bertrand M, Bader G, Lucot J, Dray-Spira R, Zureik M
JAMA
. 2018 Jan;
319(4):375-387.
PMID: 29362796
Importance: Safety of hysteroscopic sterilization has been recently questioned following reports of general symptoms such as allergy, tiredness, and depression in addition to associated gynecological results such as pelvic pain,...
9.
Bouillon K, Bertrand M, Boudali L, Ducimetiere P, Dray-Spira R, Zureik M
J Am Heart Assoc
. 2016 Nov;
5(11).
PMID: 27799233
Background: Several studies have recently examined the risks of bleeding and of ischemic stroke and systemic embolism associated with perioperative heparin bridging anticoagulation in patients with nonvalvular atrial fibrillation. However,...
10.
Bouillon K, Bertrand M, Maura G, Blotiere P, Ricordeau P, Zureik M
Lancet Haematol
. 2015 Dec;
2(4):e150-9.
PMID: 26687957
Background: Patients with non-valvular atrial fibrillation who are receiving or have been previously exposed to a vitamin K antagonist could be switched to a non-vitamin K-antagonist oral anticoagulant (NOAC) but...